doi: 10.7326/M15-0143.
How to Monitor Patients Receiving Direct Oral Anticoagulants for Stroke Prevention in Atrial Fibrillation: A Practice Tool Endorsed by Thrombosis Canada, the Canadian Stroke Consortium, the Canadian Cardiovascular Pharmacists Network, and the Canadian Cardiovascular Society
- PMID: 26121536
- DOI: 10.7326/M15-0143
Item in Clipboard
How to Monitor Patients Receiving Direct Oral Anticoagulants for Stroke Prevention in Atrial Fibrillation: A Practice Tool Endorsed by Thrombosis Canada, the Canadian Stroke Consortium, the Canadian Cardiovascular Pharmacists Network, and the Canadian Cardiovascular Society
Ann Intern Med.
.
No abstract available
Similar articles
-
Minimizing the risk of hemorrhagic stroke during anticoagulant therapy for atrial fibrillation.Expert Opin Drug Saf. 2015 May;14(5):683-95. doi: 10.1517/14740338.2015.1024222. Epub 2015 Mar 24. Expert Opin Drug Saf. 2015. PMID: 25803739 Review.
-
Personalizing oral anticoagulant treatment in patients with atrial fibrillation.Expert Rev Cardiovasc Ther. 2013 Aug;11(8):959-73. doi: 10.1586/14779072.2013.818819. Epub 2013 Aug 19. Expert Rev Cardiovasc Ther. 2013. PMID: 23957907 Review.
-
Bleeding risk assessment in patients with atrial fibrillation who are taking oral anticoagulants.Hosp Pract (1995). 2013 Feb;41(1):71-8. doi: 10.3810/hp.2013.02.1012. Hosp Pract (1995). 2013. PMID: 23466969 Review.
-
Antithrombotic treatment in atrial fibrillation.Heart. 2007 Jan;93(1):39-44. doi: 10.1136/hrt.2006.099911. Epub 2006 Sep 4. Heart. 2007. PMID: 16952971 Free PMC article. Review. No abstract available.
-
MY APPROACH to the practical management of anticoagulation in patients with atrial fibrillation.Trends Cardiovasc Med. 2016 Apr;26(3):292. doi: 10.1016/j.tcm.2015.05.022. Epub 2016 Jan 19. Trends Cardiovasc Med. 2016. PMID: 26874917 No abstract available.
Cited by
-
Assessment of a Pharmacist-Led Direct Oral Anticoagulant Monitoring Clinic.Can J Hosp Pharm. 2021 Winter;74(1):7-14. Epub 2021 Jan 1. Can J Hosp Pharm. 2021. PMID: 33487649 Free PMC article.
-
Creatinine monitoring patterns in the setting of direct oral anticoagulant therapy for non-valvular atrial fibrillation.J Thromb Thrombolysis. 2019 Oct;48(3):500-505. doi: 10.1007/s11239-019-01883-0. J Thromb Thrombolysis. 2019. PMID: 31111434 Free PMC article.
-
Factors That Determine the Prothrombin Time in Patients With Atrial Fibrillation Receiving Rivaroxaban.Clin Appl Thromb Hemost. 2018 Dec;24(9_suppl):188S-193S. doi: 10.1177/1076029618800830. Epub 2018 Sep 24. Clin Appl Thromb Hemost. 2018. PMID: 30244598 Free PMC article. Clinical Trial.
-
A pharmacist checklist for direct oral anticoagulant management: Raising the bar.Can Pharm J (Ott). 2018 Feb 9;151(2):102-106. doi: 10.1177/1715163518756926. eCollection 2018 Mar-Apr. Can Pharm J (Ott). 2018. PMID: 29531627 Free PMC article. No abstract available.
-
Preventability of serious thromboembolic and bleeding events related to the use of oral anticoagulants: a prospective study.Br J Clin Pharmacol. 2018 Jul;84(7):1544-1556. doi: 10.1111/bcp.13580. Epub 2018 Apr 17. Br J Clin Pharmacol. 2018. PMID: 29522647 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
